Related references
Note: Only part of the references are listed.Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden
Yu Kataoka et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)
HDL inhibits saturated fatty acid mediated augmentation of innate immune responses in endothelial cells by a novel pathway
Wei-Yang Zhang et al.
ATHEROSCLEROSIS (2017)
High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling
Emiel P. C. van der Vorst et al.
CELL METABOLISM (2017)
New Therapeutic Approaches to the Treatment of Dyslipidemia
Daniel J. Rader
CELL METABOLISM (2016)
Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages
Chongren Tang et al.
JOURNAL OF LIPID RESEARCH (2016)
Novel anti-inflammatory therapies for the treatment of atherosclerosis
Razi Khan et al.
ATHEROSCLEROSIS (2015)
Towards programming immune tolerance through geometric manipulation of phosphatidylserine
Reid A. Roberts et al.
BIOMATERIALS (2015)
HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export
Xian-Ming Du et al.
CIRCULATION RESEARCH (2015)
Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?
Philip J. Barter et al.
CLINICAL THERAPEUTICS (2015)
Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1
Aaron M. Fond et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis
Huan Tao et al.
JOURNAL OF LIPID RESEARCH (2015)
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA
Ruud S. Kootte et al.
JOURNAL OF LIPID RESEARCH (2015)
Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κB
Ji-Woong Kwon et al.
SCIENTIFIC REPORTS (2015)
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice
Claudine Tardy et al.
ATHEROSCLEROSIS (2014)
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
Dominic De Nardo et al.
NATURE IMMUNOLOGY (2014)
HDL-targeted therapies: progress, failures and future
Bronwyn A. Kingwell et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Fatiha Tabet et al.
NATURE COMMUNICATIONS (2014)
Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities
Laurent Camont et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?
Ernst J. Schaefer
CURRENT OPINION IN LIPIDOLOGY (2013)
ATPase activity of human ABCG1 is stimulated by cholesterol and sphingomyelin
Hiroshi Hirayama et al.
JOURNAL OF LIPID RESEARCH (2013)
Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk
Borge G. Nordestgaard et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Interleukin-6 Protects Human Macrophages from Cellular Cholesterol Accumulation and Attenuates the Proinflammatory Response
Eric Frisdal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages
Hong Mei Ma et al.
LABORATORY INVESTIGATION (2011)
Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells
Manuela Augsten et al.
PHYSIOLOGICAL GENOMICS (2011)
Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair
Tamar Harel-Adar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent
Sandra Larrede et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Cardiovascular Biology of Interleukin-6
Mahinda Y. Abeywardena et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Role for TNF in atherosclerosis? Lessons from autoimmune disease
Gayle E. McKellar et al.
NATURE REVIEWS CARDIOLOGY (2009)
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
Ruth Frikke-Schmidt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages
James P. Luyendyk et al.
JOURNAL OF IMMUNOLOGY (2008)
Apoptotic mimicry:: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo
G. C. Ramos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI/Cla-1 receptor
Morgan Treguier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Apoptotic cells induce a phosphatidyiserine-dependent homeostatic response from phagocytes
Robert S. Kiss et al.
CURRENT BIOLOGY (2006)
Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues
Thierry Huby et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
M Gilchrist et al.
NATURE (2006)
Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt
RA Pengal et al.
MOLECULAR IMMUNOLOGY (2006)
Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia
J Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo
PR Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2005)
Phosphatidylserine receptor cooperates with high-density lipoprotein receptor in recognition of apoptotic cells by thymic nurse cells
WM Cao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells
M Guha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of peroxisome proliferator-activated receptor-γ-mediated gene expression -: A new mechanism of action for high density lipoprotein
JH Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Scavenger receptor class B, type I-mediated uptake of various lipids into cells - Influence of the nature of the donor particle interaction with the receptor
ST Thuahnai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
